GENEVA, Sept. 18 -- ISM BIO LLC filed a patent application (US2026/016650) for “AN ISOTOPE SELECTIVE MODULATOR COMBINED WITH AN ANTICANCER AGENT FOR USE IN THE TREATMENT OF CANCER / METASTASIS”. With publication no. WO/2026/187556, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 33/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....